MC0704
Based on 1 Customer Validation
MC0704 is a STAT3 inhibitor with an IC50 value of 2.13 μM. MC0704 induces cell apoptosis and cell cycle arrest. MC0704 shows antitumor activity in mouse breast cancer models. MC0704 can be used for the research of metastatic triple-negative breast cancer (mTNBC).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.34%
- CAS No.: 3034176-57-0
- Formule: C29H21BrN4O2
- Masse moléculaire:537.41
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Immunology/Inflammation Compound Library
HY-L007
-
JAK/STAT Compound Library
HY-L008
-
Kinase Inhibitor Library
HY-L009
-
Stem Cell Signaling Compound Library
HY-L017
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
-
Differentiation Inducing Compound Library
HY-L038
-
Anti-Breast Cancer Compound Library
HY-L074
-
Anti-Lung Cancer Compound Library
HY-L075
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Anti-Blood Cancer Compound Library
HY-L079
-
Anti-Obesity Compound Library
HY-L087
-
Transcription Factor-Targeted Library
HY-L090
-
Cancer Stem Cells Compound Library
HY-L135
-
Anti-Hematopathy Compound Library
HY-L171
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-231 | IC50 |
2.96 μM
Compound: MC0704
|
Antiproliferative activity against docetaxel-resistant human MDA-MB-231-DTR cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
Antiproliferative activity against docetaxel-resistant human MDA-MB-231-DTR cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
|
[PMID: 36786551] |
| MDA-MB-231 | IC50 |
2.98 μM
Compound: MC0704
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36786551] |
| MDA-MB-231 | IC50 |
3.11 μM
Compound: MC0704
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
|
[PMID: 36786551] |
| MDA-MB-231 | IC50 |
3.24 μM
Compound: MC0704
|
Antiproliferative activity against docetaxel-resistant human MDA-MB-231-DTR cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against docetaxel-resistant human MDA-MB-231-DTR cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36786551] |
| MRC5 | IC50 |
33.25 μM
Compound: MC0704
|
Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay
|
[PMID: 36786551] |
MC0704 (0-50 μM; 72 h) shows cytotoxicity to HEK-293, lung epithelial normal (MRC-5), MDA-MB 231, MDA-MB-231 paclitaxel-resistant (MDA-MB-231-PTR) and MDA-MB-231 docetaxel-resistant (MDA-MB-231-DTR) cells with IC50 values of 3.11, 33.25, 2.98, 3.24 and 2.87 μM, respectively[1]. MC0704 (0, 0.4, 2, 10 and 50 μM; 24 h) inhibits activity of STAT3 with an IC50 value of 2.13 μM[1]. MC0704 (5 μM; 24 h) suppresses the activation of STAT3[1]. MC0704 (0, 2.5, 5 and 10 μM; 36-48 h) increases the cell cycle arrest at the G2/M phase and induces apoptosis in MDA-MB-231-DTR cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK-293 and MRC-5 cell lines
-
Concentration:0-50 μM
-
Incubation Time:72 hours
-
Result:Showed cytotoxicity to HEK-293 and MRC-5 cells.
-
Cell Line:MDA-MB-231 TNBC cell line
-
Concentration:5 μM
-
Incubation Time:24 hour
-
Result:Inhibited the expression of p-STAT3.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female BALB/c-nu mice with MDA-MB-231-DTR cells transplant[1]
-
Dosage:10 mg/kg
-
Administration:Intraperitoneal injection; 10 mg/kg, once daily for 12 days
-
Result:Significantly inhibited tumor growth without overt toxicity, and reversed the mesenchymal marker vimentin and epithelial marker E-cadherin expression changes.
Chemical Information
-
CAS No. 3034176-57-0
-
Appearance Solid
-
Masse moléculaire 537.41
-
Formule C29H21BrN4O2
-
Color Light yellow to yellow
-
SMILES
O=C(C1=NC(C(NCCC2=CNC3=C2C=CC=C3)=O)=CC4=C1NC5=CC=CC=C54)C6=CC=C(C=C6)Br
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 25 mg/mL (46.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (278 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.8608 mL | 9.3039 mL | 18.6078 mL | 46.5194 mL |
| 5 mM | 0.3722 mL | 1.8608 mL | 3.7216 mL | 9.3039 mL | |
| 10 mM | 0.1861 mL | 0.9304 mL | 1.8608 mL | 4.6519 mL | |
| 15 mM | 0.1241 mL | 0.6203 mL | 1.2405 mL | 3.1013 mL | |
| 20 mM | 0.0930 mL | 0.4652 mL | 0.9304 mL | 2.3260 mL | |
| 25 mM | 0.0744 mL | 0.3722 mL | 0.7443 mL | 1.8608 mL | |
| 30 mM | 0.0620 mL | 0.3101 mL | 0.6203 mL | 1.5506 mL | |
| 40 mM | 0.0465 mL | 0.2326 mL | 0.4652 mL | 1.1630 mL |
Powered by Bioz